正文共2000字预计阅读时间6分钟2025年5月27日,渤健与成立仅7个月的RNAi技术公司City Therapeutics达成协议,共同开发新型中枢神经系统疗法。根据协议,City将获得1600万美元预付款和3000万美元的投资,并有资格获得高达10亿美元的里程碑付款以及销售分成。通过此次合作,City Therapeutics将利用其下一代的RNAi工程技术,结合Biogen专有的组织增强型...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.